Cargando…
Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study
BACKGROUND: Despite the advances in medical and interventional treatment modalities, some patients develop epicardial coronary artery reperfusion but not myocardial reperfusion after primary percutaneous coronary intervention (PCI), known as no-reflow. The goal of this study was to evaluate the safe...
Autores principales: | Aksu, Tolga, Guler, Tumer Erdem, Colak, Ayse, Baysal, Erkan, Durukan, Mine, Sen, Taner, Guray, Umit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353473/ https://www.ncbi.nlm.nih.gov/pubmed/25885120 http://dx.doi.org/10.1186/s12872-015-0004-6 |
Ejemplares similares
-
Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
por: Darwish, Ahmed, et al.
Publicado: (2022) -
Efficacy and safety of intracoronary epinephrine for the management
of the no-reflow phenomenon following percutaneous coronary interventions: a
systematic-review study
por: Jafari Afshar, Elmira, et al.
Publicado: (2023) -
Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)
por: Khan, Kamran Ahmed, et al.
Publicado: (2022) -
Catheter Ablation of Atrioventricular Block: From Diagnosis to Selection of Proper Treatment
por: Baysal, Erkan, et al.
Publicado: (2020) -
Predictors of atrial fibrillation recurrence after cryoballoon ablation
por: Aksu, Tolga, et al.
Publicado: (2015)